⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REVB News
Revelation Biosciences, Inc. Common Stock
Form 8-K
sec.gov
REVB
REVBW
Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025
accessnewswire.com
REVB
Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026
accessnewswire.com
REVB
Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds
accessnewswire.com
REVB
Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI
accessnewswire.com
REVB
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)
accessnewswire.com
REVB
Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
accessnewswire.com
REVB
Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development
accessnewswire.com
REVB
Kontigo Raises $20M Seed Round to Build the Bank of the Future - A Fast-growing Stablecoin Neobank
accessnewswire.com
REVB
BTC-USD
Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting
accessnewswire.com
REVB